December 22, 2016
We have now completed some 20 case of ThermiVa for women presenting with various vaginal related complaints including urinary incontinence, laxity, dryness and diminished sensitivity. These conditions have ranged from being mildly annoying to being a significant compromise to the patient’s quality of life. The outcomes have been mostly outstanding with truly remarkable patient satisfaction.
Suboptimal results in a minority of more mature patients will typically require adjunctive hormonal therapies to improve the quality of tissues before another cycle of ThermiVa treatment can be re-instituted.